Metastatic liver disease--a review

Area of Science:

• Oncology
• Hepatobiliary Surgery

Background:

• The liver is a frequent site for metastasis from various primary malignancies.
• Increased screening enables earlier detection of liver metastases.
• Surgical hepatic resection for metastatic cancer is increasingly performed with improved techniques.

Purpose of the Study:

• To review advancements in the surgical and therapeutic management of liver metastases.
• To highlight the impact of new techniques and therapies on patient prognosis.

Main Methods:

• Review of current surgical techniques for hepatic resection.
• Discussion of novel therapeutic modalities including transarterial immuno-chemotherapy and isolated liver perfusion.
• Analysis of outcomes in patients undergoing treatment for metastatic liver disease.

Main Results:

• Improved surgical procedures have led to better prognosis with reduced mortality and morbidity.
• New therapeutic options offer additional treatment strategies before or after liver resection.
• Despite advances, locoregional recurrence of metastatic liver disease remains a significant issue.

Conclusions:

• Hepatic resection and novel therapies have improved outcomes for liver metastases.
• Further research is needed to overcome the challenge of locoregional recurrence.
• Multidisciplinary approaches are crucial for managing metastatic liver cancer effectively.